Achieving higher throughput for the bioanalysis of advanced biotherapeutics

As advanced biotherapeutics require characterization and stringent quality control to ensure the best molecules are taken forward into the clinic, there's a continued need to assess critical quality attributes early on during the cell line development process.

This whitepaper explores some of the technologies and solutions, from expression platforms to microfluidic protein characterization systems, that can be applied to save you time and money to fast-track the cell line development process, whilst ensuring biologics are produce with the required critical quality attributes. Covering areas including:

• CHOSOURCE expression platform
• Assessing N-glycan profiles of antibodies
• Expression of bispecific antibodies with transposon technology
• High-throughput characterization of bispecific antibodies

For research use only. Not for use in diagnostic procedures.